PHILADELPHIA, PA — A new study led by scientists at The Wistar Institute, in collaboration with the University of Pennsylvania Perelman School of Medicine and INOVIO, has unveiled advancements in next ...
CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...
Unlocking the therapeutic applicability of LNP-mRNA: chemistry, formulation, and clinical strategies
LNP as the novel drug delivery system enhancing mRNA therapeutic efficacy has been proved for its delivery ability. This review provides valuable insights into the current state-of-the-art of LNP mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results